source Post navigation Lilly’s Tirzepatide Cuts Type 2 Diabetes Risk by 94% in Overweight, Obese Adults – BioSpace Eli Lilly's obesity drug reduces risk of pre-diabetic patients developing disease, study finds – MedWatch